Tianda Pharmaceuticals Limited (SEHK: 455)
Health Care · Pharmaceuticals · HK
HK$0.11
+5.71% today · -35.1% 1Y
Tianda Pharmaceuticals Limited (SEHK: 455) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $30.44M.
Over the last twelve months the share price has lost 35.1%, trading between 0.08 and 0.19.
Tweenvest scores Tianda Pharmaceuticals Limited across four factors: quality 47/100, value 60/100, growth 0/100. Its strongest factor is value.
455 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $30.44M
- Revenue (TTM)
- $44.70M
- P/E
- —
- EPS
- -0.03
- Dividend yield
- —
- Beta (5Y)
- -0.06
- 52-week high
- HK$0.19
- 52-week low
- HK$0.08
- Avg volume (3M)
- —
- Shares outstanding
- 2.15B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.